# First Tracks Biotherapeutics Targets About $200 Million in Placement

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/32675
Published: 2026-10-15T18:20:40.000Z
Updated: 2026-10-15T18:20:40.000Z
Section: Business

> The company agreed to sell about 6.11 million common shares at $32.75 each to institutional investors.

First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX) agreed to sell about 6.11 million common shares to institutional investors at $32.75 each, with the placement expected to generate about $200 million in gross proceeds.